Aurinia Pharma U.S., Inc.

MD · United States · Reporting entity ID 100000961841

Total reported 2019–2025

$16.0M

#373 of 2,960 reporting companies — 0% of all reported industry payments

$7.45M in general payments across 63,942 records, plus $8.53M in research funding across 975 records.

How it breaks down

General payments $7,451,189

Research funding $8,534,947

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.